XRCC1 and melanoma: We assessed the associations of polymorphisms and haplotypes in XRCC1 with skin cancer risk in a nested case–control study within the Nurses' Health Study (219 melanoma, 286 squamous cell carcinoma (SCC) and 300 basal cell carcinoma (BCC), and 873 controls).